In Conversation: Sean Kirk, Emergent BioSolutions

Published on :

In Conversation: Sean Kirk, Emergent BioSolutions Following up on the recent article Two Maryland Biotechs Partner to Bring Coronavirus/COVID-19 Vaccine Candidate into Clinical Trials, BioBuzz had the opportunity to speak with Emergent BioSolutions Executive Vice President, Manufacturing and Technical Operations, Sean Kirk. Let’s start by having you provide a brief background on your role at [….]

This Startup is on a Mission to Decentralize Cell and Gene Therapy Clinical Trials

Published on :

This Startup is on a Mission to Decentralize Cell and Gene Therapy Clinical Trials For the cell and gene therapy revolution to be fully realized, physicians, research scientists, biomanufacturing experts, advocacy groups, regulatory bodies like the Food & Drug Administration (FDA) and other key stakeholders have to “Think Different”, as Apple famously encouraged. The “vein-to-vein”, [….]

In Conversation: Dr. Harsha K. Rajasimha, IndoUSrare

Published on :

In Conversation: Dr. Harsha K. Rajasimha, IndoUSrare BioBuzz recently sat down for a conversation with Dr. Harsha K. Rajasimha, a leading rare disease advocate, the founder of the non-profit, IndoUSrare, and the CEO of Jeeva Informatics, a leading AI and digital health company focused on decentralized clinical trials.  February is Rare Disease Month. What does [….]